Literature DB >> 30391478

A power law function describes the time- and dose-dependency of Vγ9Vδ2 T cell activation by phosphoantigens.

Chia-Hung Christine Hsiao1, Andrew J Wiemer2.   

Abstract

Phosphoantigens stimulate Vγ9Vδ2 T cells after binding to BTN3A1 in target cells and cell-cell contact. We evaluated phosphoantigens including diphosphates, bisphosphonates, and prodrugs for ability to induce leukemia cells to stimulate Vγ9Vδ2 T cell interferon-γ secretion. Most compounds displayed time-dependent activity at exposure times between 15 and 240 min. Potency (EC50 values) ranged between 8.4 nM and >100 µM. The diphosphate C-HMBPP displayed a shallow dose-response slope (Hill slope = 0.71), while the bisphosphonate slopes were steep (Hill slopes > 2), and the prodrugs intermediate. The bis-acyloxyalkyl POM2-C-HMBP showed low nanomolar potency even at an exposure time of 1 min. Mixed aryl-POM prodrugs also retained excellent potency at 15 min, while aryl-amidates were time dependent below 240 min. The sum of the dose and time logarithms is often constant, while a power law function fits most compounds. Collectively, these findings illustrate the exquisite activity of prodrugs relative to diphosphates and bisphosphonates.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  BTN3A1; Butyrophilin 3A1; CD277; Gamma delta T cell; Haber’s rule

Mesh:

Substances:

Year:  2018        PMID: 30391478      PMCID: PMC6258176          DOI: 10.1016/j.bcp.2018.10.035

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  40 in total

Review 1.  The relationship between the chemistry and biological activity of the bisphosphonates.

Authors:  Frank H Ebetino; Anne-Marie L Hogan; Shuting Sun; Maria K Tsoumpra; Xuchen Duan; James T Triffitt; Aaron A Kwaasi; James E Dunford; Bobby L Barnett; Udo Oppermann; Mark W Lundy; Alan Boyde; Boris A Kashemirov; Charles E McKenna; R Graham G Russell
Journal:  Bone       Date:  2011-04-09       Impact factor: 4.398

2.  HMBPP Analog Prodrugs Bypass Energy-Dependent Uptake To Promote Efficient BTN3A1-Mediated Malignant Cell Lysis by Vγ9Vδ2 T Lymphocyte Effectors.

Authors:  Ashley M Kilcollins; Jin Li; Chia-Hung Christine Hsiao; Andrew J Wiemer
Journal:  J Immunol       Date:  2016-06-06       Impact factor: 5.422

Review 3.  Prodrugs of phosphonates and phosphates: crossing the membrane barrier.

Authors:  Andrew J Wiemer; David F Wiemer
Journal:  Top Curr Chem       Date:  2015

4.  Cytosolic entry of bisphosphonate drugs requires acidification of vesicles after fluid-phase endocytosis.

Authors:  Keith Thompson; Michael J Rogers; Fraser P Coxon; Julie C Crockett
Journal:  Mol Pharmacol       Date:  2006-02-24       Impact factor: 4.436

5.  Key implication of CD277/butyrophilin-3 (BTN3A) in cellular stress sensing by a major human γδ T-cell subset.

Authors:  Christelle Harly; Yves Guillaume; Steven Nedellec; Cassie-Marie Peigné; Hannu Mönkkönen; Jukka Mönkkönen; Jianqiang Li; Jürgen Kuball; Erin J Adams; Sonia Netzer; Julie Déchanet-Merville; Alexandra Léger; Thomas Herrmann; Richard Breathnach; Daniel Olive; Marc Bonneville; Emmanuel Scotet
Journal:  Blood       Date:  2012-07-05       Impact factor: 22.113

6.  Effector Vγ9Vδ2 T cells dominate the human fetal γδ T-cell repertoire.

Authors:  Tanya Dimova; Margreet Brouwer; Françoise Gosselin; Joël Tassignon; Oberdan Leo; Catherine Donner; Arnaud Marchant; David Vermijlen
Journal:  Proc Natl Acad Sci U S A       Date:  2015-01-23       Impact factor: 11.205

7.  Quantitative structure-activity relationships for gammadelta T cell activation by bisphosphonates.

Authors:  John M Sanders; Subhash Ghosh; Julian M W Chan; Gary Meints; Hong Wang; Amy M Raker; Yongcheng Song; Alison Colantino; Agnieszka Burzynska; Pawel Kafarski; Craig T Morita; Eric Oldfield
Journal:  J Med Chem       Date:  2004-01-15       Impact factor: 7.446

8.  Vγ9Vδ2 TCR-activation by phosphorylated antigens requires butyrophilin 3 A1 (BTN3A1) and additional genes on human chromosome 6.

Authors:  Felipe Riaño; Mohindar M Karunakaran; Lisa Starick; Jianqiang Li; Claus J Scholz; Volker Kunzmann; Daniel Olive; Sabine Amslinger; Thomas Herrmann
Journal:  Eur J Immunol       Date:  2014-06-30       Impact factor: 5.532

9.  Evaluation of a 7-Methoxycoumarin-3-carboxylic Acid Ester Derivative as a Fluorescent, Cell-Cleavable, Phosphonate Protecting Group.

Authors:  Andrew J Wiemer; Rebekah R Shippy; Ashley M Kilcollins; Jin Li; Chia-Hung Christine Hsiao; Rocky J Barney; M Lei Geng; David F Wiemer
Journal:  Chembiochem       Date:  2015-11-19       Impact factor: 3.164

Review 10.  Nucleoside, nucleotide, and non-nucleoside inhibitors of hepatitis C virus NS5B RNA-dependent RNA-polymerase.

Authors:  Michael J Sofia; Wonsuk Chang; Phillip A Furman; Ralph T Mosley; Bruce S Ross
Journal:  J Med Chem       Date:  2012-01-23       Impact factor: 7.446

View more
  10 in total

1.  Stability and Efficiency of Mixed Aryl Phosphonate Prodrugs.

Authors:  Benjamin J Foust; Jin Li; Chia-Hung Christine Hsiao; David F Wiemer; Andrew J Wiemer
Journal:  ChemMedChem       Date:  2019-07-24       Impact factor: 3.466

Review 2.  Structure-Activity Relationships of Butyrophilin 3 Ligands.

Authors:  Andrew J Wiemer
Journal:  ChemMedChem       Date:  2020-05-26       Impact factor: 3.466

3.  Synthesis and Metabolism of BTN3A1 Ligands: Studies on Diene Modifications to the Phosphoantigen Scaffold.

Authors:  Nyema M Harmon; Michael M Poe; Xueting Huang; Rohit Singh; Benjamin J Foust; Chia-Hung Christine Hsiao; David F Wiemer; Andrew J Wiemer
Journal:  ACS Med Chem Lett       Date:  2022-01-27       Impact factor: 4.345

Review 4.  Hydroxy- and Amino-Phosphonates and -Bisphosphonates: Synthetic Methods and Their Biological Applications.

Authors:  Babak Kaboudin; Payam Daliri; Samaneh Faghih; Hesam Esfandiari
Journal:  Front Chem       Date:  2022-06-01       Impact factor: 5.545

5.  Ligand-induced interactions between butyrophilin 2A1 and 3A1 internal domains in the HMBPP receptor complex.

Authors:  Chia-Hung Christine Hsiao; Khiem Nguyen; Yiming Jin; Olga Vinogradova; Andrew J Wiemer
Journal:  Cell Chem Biol       Date:  2022-01-25       Impact factor: 9.039

Review 6.  Prodrugs of pyrophosphates and bisphosphonates: disguising phosphorus oxyanions.

Authors:  Emma S Rudge; Alex H Y Chan; Finian J Leeper
Journal:  RSC Med Chem       Date:  2022-03-01

7.  Generation of effector Vγ9Vδ2 T cells and evaluation of their response to phosphoantigen-loaded cells.

Authors:  Chia-Hung Christine Hsiao; Andrew J Wiemer
Journal:  STAR Protoc       Date:  2022-06-04

8.  A luciferase lysis assay reveals in vivo malignant cell sensitization by phosphoantigen prodrugs.

Authors:  Jin Li; Nicholas A Lentini; David F Wiemer; Andrew J Wiemer
Journal:  Biochem Pharmacol       Date:  2019-10-16       Impact factor: 5.858

9.  ZINC40099027 activates human focal adhesion kinase by accelerating the enzymatic activity of the FAK kinase domain.

Authors:  Shyam K More; Qinggang Wang; Emilie E Vomhof-DeKrey; James E Porter; Marc D Basson
Journal:  Pharmacol Res Perspect       Date:  2021-04

10.  Potent double prodrug forms of synthetic phosphoantigens.

Authors:  Nyema M Harmon; Xueting Huang; Megan A Schladetsch; Chia-Hung Christine Hsiao; Andrew J Wiemer; David F Wiemer
Journal:  Bioorg Med Chem       Date:  2020-07-29       Impact factor: 3.461

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.